Limitations of the IGF1 generation test in children with short stature

European Journal of Endocrinology

Volumn 166, Issue 3, 2012, Pages 351-357

  Coutant, Régis ^a   Dörr, Helmuth Günther ^b   Gleeson, Helena ^c   Argente, Jesús ^d  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c LEICESTER ROYAL INFIRMARY   (United Kingdom)

^d HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

DISEASE SEVERITY; ENDOCRINE FUNCTION TEST; GROWTH HORMONE DEFICIENCY; HEALTH SURVEY; HORMONE RESPONSE; HUMAN; INSULIN LIKE GROWTH FACTOR 1 GENERATION TEST; LARON SYNDROME; MEDICAL DECISION MAKING; PREDICTIVE VALUE; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SHORT STATURE; SIGNAL TRANSDUCTION; TURNER SYNDROME; BIOSYNTHESIS; BLOOD; BODY HEIGHT; CHILD; GROWTH DISORDER; HOSPITALIZATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

BODY HEIGHT; CHILD; GROWTH DISORDERS; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LARON SYNDROME; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 84857945257     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0618     Document Type: Review

References (52)

1. Wit JM & Camacho-Hubner C. Endocrine regulation of longitudinal bone growth. Endocrine Development 2011 21 30-41. (doi:10.1159/000328119)
2. Rosenfeld RG. Insulin-like growth factors and the basis of growth. New England Journal of Medicine 2003 349 2184-2186. (doi:10.1056/NEJMp038156)
3. Savage MO, Blum WF, Ranke MB, Postel-Vinay MC, Cotterill AM, Hall K, Chatelain PG, Preece MA & Rosenfeld RG. Clinical features and endocrine status in patients with growth hormone insensitivity (Laron syndrome). Journal of Clinical Endocrinology and Metabolism 1993 77 1465-1471. (doi:10.1210/jc.77. 6.1465)
4. Laron Z & Klinger B. Laron syndrome: clinical features, molecular pathology and treatment. Hormone Research 1994 42 198-202. (doi:10.1159/ 000184193)
5. Rosenfeld RG, Rosenbloom AL & Guevara-Aguirre J. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocrine Reviews 1994 15 369-390. (doi:10.1210/edrv-15-3-369)
6. Thalange NK, Price DA, Gill MS, Whatmore AJ, Addison GM &Clayton PE. Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity. Pediatric Research 1996 39 849-855. (doi:10.1203/ 00006450-199605000-00018)
7. Woods KA, Dastot F, Preece MA, Clark AJ, Postel-Vinay MC, Chatelain PG, Ranke MB, Rosenfeld RG, Amselem S & Savage MO. Phenotype: genotype relationships in growth hormone insensitivity syndrome. Journal of Clinical Endocrinology and Metabolism 1997 82 3529-3535. (doi:10.1210/jc.82.11.3529)
8. Chernausek SD, Backeljauw PF, Frane J, Kuntze J & Underwood LE. Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children with severe IGF-I deficiency due to growth hormone insensitivity. Journal of Clinical Endocrinology and Metabolism 2007 92 902-910. (doi:10.1210/jc.2006-1610)
9. Cotterill AM, Camacho-Hubner C, Duquesnoy P & Savage MO. Changes in serum IGF-I and IGFBP-3 concentrations during the IGF-I generation test performed prospectively in children with short stature. Clinical Endocrinology 1998 48 719-724. (doi:10.1046/j.1365-2265.1998.00407.x)
10. Salerno M, Balestrieri B, Matrecano E, Officioso A, Rosenfeld RG, Di Maio S, Fimiani G, Ursini MV & Pignata C. Abnormal GH receptor signaling in children with idiopathic short stature. Journal of Clinical Endocrinology and Metabolism 2001 86 3882-3888. (doi:10.1210/jc.86.8.3882)
11. Kamp GA, Zwinderman AH, Van Doorn J, Hackeng W, Frolich M, Schonau E & Wit JM. Biochemical markers of growth hormone (GH) sensitivity in children with idiopathic short stature: individual capacity of IGF-I generation after high-dose GH treatment determines the growth response to GH. Clinical Endocrinology 2002 57 315-325. (doi:10.1046/j.1365-2265.2002.01575.x)
12. Blair JC, Camacho-Hubner C, Miraki Moud F, Rosberg S, Burren C, Lim S, Clayton PE, Bjarnason R, Albertsson-Wikland K &Savage MO. Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature. Clinical Endocrinology 2004 60 163-168 (discussion 161-162). (doi:10.1046/j.1365-2265.2004.01957.x)
13. Wit JM & Bang P. European perspective on treatment approaches for growth failure. Pediatric Endocrinology Reviews 2008 5 (Suppl 3) 862-868.
14. Werther GA, Matthews RN, Burger HG & Herington AC. Lack of response of nonsuppressible insulin-like activity to short term administration of human growth hormone in thalassemia major. Journal of Clinical Endocrinology and Metabolism 1981 53 806-809. (doi:10.1210/jcem-53-4-806)
15. Cavallo L, Gurrado R, Gallo F, Zacchino C, De Mattia D & Tato L. Growth deficiency in polytransfused beta-thalassaemia patients is not growth hormone dependent. Clinical Endocrinology 1997 46 701-706. (doi:10.1046/j.1365- 2265.1997.1951005.x)
16. Soliman AT, El Banna N & Ansari BM. GH response to provocation and circulating IGF-I and IGF-binding protein-3 concentrations, the IGF-I generation test and clinical response to GH therapy in children with beta-thalassaemia. European Journal of Endocrinology 1998 138 394-400. (doi:10.1530/eje.0.1380394)
17. Chrysis DC, Alexandrides TK, Koromantzou E, Georgopoulos N, Vassilakos P, Kiess W, Kratsch J, Beratis NG & Spiliotis BE. Novel application of IGF-I and IGFBP-3 generation tests in the diagnosis of growth hormone axis disturbances in children with beta-thalassaemia. Clinical Endocrinology 2001 54 253-259. (doi:10.1046/j.1365-2265.2001.01198.x)
18. Rondanelli M, Caselli D, Arico M, Maccabruni A, Magnani B, Bacchella L, De Stefano A, Maghnie M, Solerte SB & Minoli L. Insulin-like growth factor I (IGF-I) and IGF-binding protein 3 response to growth hormone is impaired in HIV-infected children. AIDS Research and Human Retroviruses 2002 18 331-339. (doi:10.1089/088922202753519106)
19. Tsatsoulis A, Siamopoulou A, Petsoukis C, Challa A, Bairaktari E &Seferiadis K. Study of growth hormone secretion and action in growth-retarded children with juvenile chronic arthritis (JCA). Growth Hormone & IGF Research 1999 9 143-149. (doi:10.1054/ghir.1999.0099)
20. Marini JC, Bordenick S, Heavner G, Rose S, Hintz R, Rosenfeld R &Chrousos GP. The growth hormone and somatomedin axis in short children with osteogenesis imperfecta. Journal of Clinical Endocrinology and Metabolism 1993 76 251-256. (doi:10.1210/jc.76.1.251)
21. De Ravin SS, Shum E, Zarember KA, Rezvani G, Rosenfeld RG, Stratakis CA & Malech HL. Short stature in partially corrected X-linked severe combined immunodeficiency - suboptimal response to growth hormone. Journal of Pediatric Endocrinology &Metabolism 2008 21 1057-1063. (doi:10.1515/JPEM.2008.21.11. 1057)
22. Collett-Solberg PF, Pessoa de Queiroz AN, Cardoso ME, Jusan RC, Vaisman M & Guimaraes MM. The correlation of the IGF-I, IGFBP-3, and ALS generation test to height velocity after 6 months of recombinant growth hormone therapy in girls with Turner syndrome. Growth Hormone & IGF Research 2006 16 240-246. (doi:10.1016/j.ghir.2006.06.002)
23. Pessoa de Queiroz AN, Collett-Solberg PF, Cardoso ME, Jusan RC, Vaisman M & Guimaraes MM. IGF-I, IGFBP-3 and ALS generation test in Turner syndrome. Growth Hormone & IGF Research 2007 17 254-260. (doi:10.1016/j.ghir.2007.03. 003)
24. Rosenfeld RG, Kemp SF & Hintz RL. Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate. Journal of Clinical Endocrinology and Metabolism 1981 53 611-617. (doi:10.1210/jcem-53-3-611)
25. Schwarze CP, Wollmann HA, Binder G & Ranke MB. Short-term increments of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 predict the growth response to growth hormone (GH) therapy in GH-sensitive children. Acta Paediatrica Supplement 1999 88 200-208. (doi:10.1111/j.1651-2227.1999.tb14392.x)
26. Coutant R, de Casson FB, Rouleau S, Douay O, Mathieu E, Gatelais F, Bouhours-Nouet N, Voinot C, Audran M & Limal JM. Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents. Journal of Clinical Endocrinology and Metabolism 2004 89 6185-6192. (doi:10.1210/jc.2004-0814)
27. Gleeson HK, Lissett CA & Shalet SM. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity. Journal of Clinical Endocrinology and Metabolism 2005 90 1061-1067. (doi:10.1210/jc.2004- 0501)
28. Lissett CA & Shalet SM. The impact of dose and route of estrogen administration on the somatotropic axis in normal women. Journal of Clinical Endocrinology and Metabolism 2003 88 4668-4672. (doi:10.1210/jc.2003-022036)
29. Blum WF, Cotterill AM, Postel-Vinay MC, Ranke MB, Savage MO &Wilton P. Improvement of diagnostic criteria in growth hormone insensitivity syndrome: solutions and pitfalls. Pharmacia Study Group on insulin-like growth factor I treatment in growth hormone insensitivity syndromes. Acta Paediatrica Supplement 1994 399 117-124. (doi:10.1111/j.1651-2227.1994.tb13303.x)
30. Yordam N, Kandemir N, Erkul I, Kurdoglu S & Hatun S. Review of Turkish patients with growth hormone insensitivity (Laron type). European Journal of Endocrinology 1995 133 539-542. (doi:10.1530/eje.0.1330539)
31. Buckway CK, Guevara-Aguirre J, Pratt KL, Burren CP &Rosenfeld RG. The IGF-I generation test revisited: a marker of GH sensitivity. Journal of Clinical Endocrinology and Metabolism 2001 86 5176-5183. (doi:10.1210/jc.86.11. 5176)
32. Buckway CK, Selva KA, Pratt KL, Tjoeng E, Guevara-Aguirre J &Rosenfeld RG. Insulin-like growth factor binding protein-3 generation as a measure of GH sensitivity. Journal of Clinical Endocrinology and Metabolism 2002 87 4754-4765. (doi:10.1210/jc.2002-020045)
33. Besson A, Salemi S, Eble A, Joncourt F, Gallati S, Jorge AA &Mullis PE. Primary GH insensitivity (Laron syndrome) caused by a novel 4 kb deletion encompassing exon 5 of the GH receptor gene: effect of intermittent long-term treatment with recombinant human IGF-I. European Journal of Endocrinology 2004 150 635-642. (doi:10.1530/eje.0.1500635)
34. Savage MO, Blair JC, Jorge AJ, Street ME, Ranke MB & Camacho- Hübner C. IGFs and IGFBPs in GH insensitivity. Endocrine Development 2005 9 100-106. (doi:10.1159/000085760)
35. Yang C, Chen JY, Lai CC, Lin HC, Yeh GC & Hsu HH. Clinical, biochemical and molecular investigations of three Taiwanese children with Laron syndrome. Journal of Pediatric Endocrinology &Metabolism 2004 17 165-171. (doi:10.1515/JPEM.2004.17.2.165)
36. Berg MA, Argente J, Chernausek S, Gracia R, Guevara-Aguirre J, Hopp M, Perez-Jurado L, Rosenbloom A, Toledo SP & Francke U. Diverse growth hormone receptor gene mutations in Laron syndrome. American Journal of Human Genetics 1993 52 998-1005. (Pubitemid 23313722)
37. Wu S, Walenkamp MJ, Lankester A, Bidlingmaier M, Wit JM & De Luca F. Growth hormone and insulin-like growth factor I insensitivity of fibroblasts isolated from a patient with an IκBα mutation. Journal of Clinical Endocrinology and Metabolism 2010 95 1220-1228. (doi:10.1210/jc.2009-1662)
38. Kofoed EM, Hwa V, Little B, Woods KA, Buckway CK, Tsubaki J, Pratt KL, Bezrodnik L, Jasper H, Tepper A, Heinrich JJ &Rosenfeld RG. Growth hormone insensitivity associated with a STAT5b mutation. New England Journal of Medicine 2003 349 1139-1147. (doi:10.1056/NEJMoa022926)
39. Hwa V, Little B, Adiyaman P, Kofoed EM, Pratt KL, Ocal G, Berberoglu M & Rosenfeld RG. Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b. Journal of Clinical Endocrinology and Metabolism 2005 90 4260-4266. (doi:10.1210/jc.2005- 0515)
40. Buckway CK, Selva KA, Burren CP, Pratt KL, Tjoeng E, Guevara-Aguirre J & Rosenfeld RG. IGF generation in short stature. Journal of Pediatric Endocrinology & Metabolism 2002 15 (Suppl 5) 1453-1454. (Pubitemid 36024226)
41. Bouhours-Nouet N, Gatelais F, Boux de Casson F, Rouleau S &Coutant R. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature. Journal of Clinical Endocrinology and Metabolism 2007 92 629-635. (doi:10.1210/jc.2005-2631)
42. Jorge AA, Souza SC, Arnhold IJ & Mendonca BB. Poor reproducibility of IGF-I and IGF binding protein-3 generation test in children with short stature and normal coding region of the GH receptor gene. Journal of Clinical Endocrinology and Metabolism 2002 87 469-472. (doi:10.1210/jc.87.2.469)
43. Rosenfeld RG, Buckway C, Selva K, Pratt KL & Guevara-Aguirre J. Insulin-like growth factor (IGF) parameters and tools for efficacy: the IGF-I generation test in children. Hormone Research 2004 62 (Suppl 1) 37-43. (doi:10.1159/000080757)
44. Coutant R, Boux de Casson F, Rouleau S, Douay O, Mathieu E, Audran M & Limal JM. Body composition, fasting leptin, and sex steroid administration determine GH sensitivity in peripubertal short children. Journal of Clinical Endocrinology and Metabolism 2001 86 5805-5812. (doi:10.1210/jc.86.12.5805)
45. Gleeson HK & Shalet SM. Reproducibility of the IGF-1 generation test in adults. Program of the 88th Annual Meeting of The Endocrine Society, Boston, MA 2006, pp 210 (Abstract P1-195).
46. Carel JC, Coste J, Gendrel C & Chaussain JL. Pharmacological testing for the diagnosis of growth hormone deficiency. Growth Hormone & IGF Research 1998 8 (Suppl A) 1-8. (doi:10.1016/S1096-6374(98)80001-4)
47. Clemmons DR. IGF-I assays: current assay methodologies and their limitations. Pituitary 2007 10 121-128. (doi:10.1007/s11102-007-0032-z)
48. Midyett LK, Rogol AD, Van Meter QL, Frane J & Bright GM. Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial. Journal of Clinical Endocrinology and Metabolism 2010 95 611-619. (doi:10.1210/jc.2009-0570)
49. Rosenbloom AL & Rivkees SA. Off-label use of recombinant IGF-I to promote growth: is it appropriate? Journal of Clinical Endocrinology and Metabolism 2010 95 505-508. (doi:10.1210/jc.2009-2450)
50. Toyoshima MT, Castroneves LA, Costalonga EF, Mendonca BB, Arnhold IJ & Jorge AA. Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature. Clinical Endocrinology 2007 67 500-504. (doi:10.1111/j.1365-2265.2007.02915.x)
51. Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V &Bougneres P. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nature Genetics 2004 36 720-724. (doi:10.1038/ng1379)
52. Binder G, Baur F, Schweizer R & Ranke MB. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-forgestational- age children. Journal of Clinical Endocrinology and Metabolism 2006 91 659-664. (doi:10.1210/jc.2005- 1581)